---
title: "Galera Therapeutics, Inc. SEC filings"
url: https://altstreet.investments/edgar/1563577
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Galera Therapeutics, Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | Galera Therapeutics, Inc. |
| CIK | 1563577 |
| Filing family | Form 15 / Schedule TO |

## Filings (7 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| August 4, 2026 | 15-12G | Form 15 / Schedule TO | https://www.sec.gov/Archives/edgar/data/1563577/000119312526332816/ |
| January 14, 2025 | D | Form D | https://www.sec.gov/Archives/edgar/data/1563577/000095012325000263/ |
| January 13, 2025 | D | Form D | https://www.sec.gov/Archives/edgar/data/1563577/000095012325000248/ |
| September 17, 2018 | D | Form D | https://www.sec.gov/Archives/edgar/data/1563577/000095013818000520/ |
| November 28, 2016 | D | Form D | https://www.sec.gov/Archives/edgar/data/1563577/000095013816001481/ |
| October 14, 2015 | D | Form D | https://www.sec.gov/Archives/edgar/data/1563577/000095013815000666/ |
| August 6, 2014 | D | Form D | https://www.sec.gov/Archives/edgar/data/1563577/000095013814000577/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1563577
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001563577&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1563577
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
